glp-1 and pancreatic cancer glp 1 cancer-New Study, ., article text provided outlines a landmark GLP-1 Agonists and Pancreatitis Risk:

23 This need for injection can limit patient use and may also restrict the possibility of combining these drugs in fixed-dose treatments with other therapies for cardio-metabolic conditions

GIP is a hormone that stimulates the release of insulin, which not only helps control blood sugar levels, but also promotes muscle growth by encouraging protein build-up and discouraging protein breakdown in muscle tissue

Its still a work in progress, but one I feel more in control of now

References Ronn, J., Jensen, E

Vollmer K, Holst JJ, Baller B, Ellrichmann M, Nauck MA, Schmidt WE, Meier JJ

These drugs were first approved to help regulate blood sugar in people with type 2 diabetes but were later discovered to promote weight loss, among other health benefits